QPPV.COM KNOWLEDGE ASSESSMENT

Drug-Induced Cardiac Toxicity: Cardiovascular Safety Assessment in Clinical Development and Pharmacovigilance

Test your understanding of the concepts covered by Drug-Induced Cardiac Toxicity: Cardiovascular Safety Assessment in Clinical Development and Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which sequence best reflects a medically sound review of a potential cardiovascular safety case?

Assign causality, then verify the diagnosis if challenged Confirm the phenotype, establish baseline and timeline, review exposure and alternative causes, then assess causality Classify the case solely from the reported MedDRA term Use a statistical signal as the diagnosis and omit individual case review

Question 2 of 10 A patient has an elevated high-sensitivity cardiac troponin, unchanged ECG, no chest pain, severe renal impairment and recent sepsis. What can be concluded from the troponin result alone?

Acute myocardial infarction is established Drug-induced myocarditis is established Myocardial injury is indicated, but its cause and clinical diagnosis remain unresolved The result has no clinical significance

Question 3 of 10 A single automated post-dose QTc value is a major outlier in a clinical trial. What should happen next?

It should automatically be counted as a treatment-related proarrhythmic event It should be discarded without review because automated measurements are never useful It should trigger review of measurement quality, baseline QTc, heart rate, timing, exposure, electrolytes and repeat measurements It should be converted into a troponin result for confirmation

Question 4 of 10 Which statement best explains why cardiovascular safety assessment cannot focus exclusively on QT/QTc?

QT/QTc measurements are not related to cardiac electrophysiology Cardiovascular toxicity can also involve myocardial injury, ventricular dysfunction, arrhythmias, blood pressure, vascular effects and clinical outcomes QT/QTc is relevant only to nonclinical studies All clinically important cardiac toxicity causes QT prolongation

Question 5 of 10 What is the main purpose of correcting the QT interval for heart rate?

To convert QT into a biomarker of myocardial infarction To reduce the confounding effect of different heart rates when assessing ventricular repolarization To determine whether a patient has structural heart disease To prove that any QTc change is treatment-related

Question 6 of 10 Which combination would most strongly support urgent consideration of a myocarditis-like presentation in a patient receiving an immune-modulating medicine?

Mild isolated hypertension without symptoms Troponin elevation alone with no other findings New chest discomfort, troponin elevation, conduction abnormality and reduced ventricular function A stable baseline ECG and normal cardiac biomarkers

Question 7 of 10 A patient has a QTc of 510 ms while markedly hypokalemic and taking another medicine known to affect potassium balance. What is the most appropriate safety conclusion?

The QTc finding should be attributed exclusively to the investigational drug The QTc finding should be ignored because electrolyte abnormalities are common The patient has clinically important QT prolongation with multiple potential contributors requiring medical assessment The finding proves that torsades de pointes has occurred

Question 8 of 10 A patient's LVEF falls from 62% to 48%, but the patient has no heart-failure symptoms. Which interpretation is most appropriate?

Symptomatic heart failure is automatically established The result is clinically irrelevant because symptoms are absent The finding may represent myocardial dysfunction and requires confirmation and evaluation of other causes The result proves myocarditis

Question 9 of 10 Why can concentration-QTc analysis be more informative than comparing QTc changes solely by nominal dose?

Nominal dose always predicts the same systemic exposure in every patient QTc is unrelated to pharmacokinetic exposure Patients receiving the same dose may have different concentrations because of clearance, interactions, organ impairment and other factors Concentration-QTc analysis eliminates the need for ECG measurements

Question 10 of 10 What is the correct interpretation of a statistical signal involving sudden cardiac death in a pharmacovigilance database?

It establishes that the medicinal product caused every reported death It is a hypothesis-generating finding requiring clinical and epidemiological evaluation It can be ignored unless a QTc study was conducted It proves a class effect regardless of other evidence

Drug-Induced Cardiac Toxicity: Cardiovascular Safety Assessment in Clinical Development and Pharmacovigilance

Cookie Settings